Gamma-tocopherol, a major form of vitamin E in diets: Insights into antioxidant and anti-inflammatory effects, mechanisms, and roles in disease management.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing in vitro, animal, and human studies with no systematic review methodology.
PubMed 34896589 · doi:10.1016/j.freeradbiomed.2021.12.012
What was done
This narrative review synthesized literature spanning over 25 years on the antioxidant and anti-inflammatory activities of gamma-tocopherol (γT) and its metabolites relative to alpha-tocopherol (αT). It examined in vitro mechanistic data, animal disease models of asthma, cancer, and inflammation, and clinical studies in patients with kidney disease and mild asthma.
What was found
The abstract reports directional and mechanistic findings without quantitative numbers. γT, unlike αT, traps reactive nitrogen species by forming 5-nitro-γT, blocks 5-lipoxygenase translocation in leukocytes to inhibit leukotrienes, decreases cyclooxygenase-2-mediated prostaglandins in macrophages, and inhibits cancer cell growth while sparing healthy cells. Its metabolites, 13'-carboxychromanol and carboxyethyl-hydroxychroman, exhibit COX-1/COX-2/5-LOX inhibition and natriuretic activity, respectively. Preclinical supplementation mitigated disease symptoms in inflammation, asthma, and cancer models, and clinical supplementation reduced inflammatory markers in kidney disease and mild asthma.
Why it matters
This review highlights that γT has distinct biochemical and anti-inflammatory activities not replicated by αT, supporting its potential utility for managing inflammatory conditions.
Limits
As a narrative review, the paper lacks systematic search criteria, quality appraisal, and meta-analytic pooling. The abstract provides no sample sizes, dosages, specific numerical outcomes, or effect sizes for the cited preclinical models and human trials.
Cited by
- supports High doses of alpha-tocopherol lower circulating levels of gamma-tocopherol in the body.